Skip to main content

Apollo Endosurgery, Inc. (APEN)

NASDAQ: APEN · Delayed Price · USD
9.16 0.28 (3.15%)
Sep 20, 2021 4:00 PM EDT - Market closed
Market Cap249.14M
Revenue (ttm)56.15M
Net Income (ttm)-13.72M
Shares Out27.27M
EPS (ttm)-0.54
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume128,257
Open8.74
Previous Close8.88
Day's Range8.64 - 9.20
52-Week Range1.36 - 10.04
Beta2.31
AnalystsBuy
Price Target14.25 (+55.6%)
Est. Earnings DateNov 4, 2021

About APEN

Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to place full thickness sutures and secure the approximation of tissue through a flexible endoscope. It also provides Orbera, an intragastric balloon system that reduces stomach capacity causing patients to consume less following the procedure, and delays gastric content em...

IndustryHealth Care Equipment & Supplies
Founded2005
CEOGary Atkinson
Employees158
Stock ExchangeNASDAQ
Ticker SymbolAPEN
Full Company Profile

Financial Performance

In 2020, APEN's revenue was $42.05 million, a decrease of -17.09% compared to the previous year's $50.71 million. Losses were -$22.61 million, -17.57% less than in 2019.

Financial Statements

Analyst Forecast

According to 2 analysts, the average rating for APEN stock is "Buy." The 12-month stock price forecast is 14.25, which is an increase of 55.57% from the latest price.

Price Target
$14.25
(55.57% upside)
Analyst Consensus: Buy

News

Apollo Endosurgery to Present at Lake Street's 5th Annual Best Ideas Growth Conference

AUSTIN, TX / ACCESSWIRE / September 13, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today an...

1 week ago - Accesswire

Apollo Endosurgery, Inc. (APEN) Reports Q2 Loss, Tops Revenue Estimates

Apollo Endosurgery, Inc. (APEN) delivered earnings and revenue surprises of 35.29% and 17.14%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

1 month ago - Zacks Investment Research

Apollo Endosurgery, Inc. Reports Record Endoscopy Revenue in Second Quarter, Raises Full-Year Outlook Conference Call...

AUSTIN, TX / ACCESSWIRE / August 3, 2021 / Apollo Endosurgery, Inc. ("Apollo") (Nasdaq:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announ...

1 month ago - Accesswire

Will Apollo Endosurgery, Inc. (APEN) Report Negative Q2 Earnings? What You Should Know

Apollo Endosurgery, Inc. (APEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 month ago - Zacks Investment Research

Apollo Endosurgery to Report Second Quarter Financial Results on August 3, 2021

AUSTIN, TX / ACCESSWIRE / July 27, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in next-generation minimally invasive medical devices for gastrointestinal and bariatric proc...

1 month ago - Accesswire

Apollo Endosurgery Appoints Jeffrey G. Black as Chief Financial Officer

Veteran Executive Brings 30 Years of Financial and Operational Leadership Experience AUSTIN, TX / ACCESSWIRE / July 16, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minim...

2 months ago - Accesswire

MERIT Study Investigators Announce Successful Achievement of the Study's Primary Efficacy & Safety Endpoints

AUSTIN, TX / ACCESSWIRE / June 14, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, announce...

3 months ago - Accesswire

Apollo Endosurgery to Present at June Investor Conferences

AUSTIN, TX / ACCESSWWIRE / June 1, 2021 / Apollo Endosurgery, Inc. ("Apollo") (Nasdaq:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures today announce...

3 months ago - Accesswire

Apollo Endosurgery's Innovative OverStitch(TM) Endoscopic Suturing System Highlighted During Digestive Disease Week 2021

AUSTIN, TX / ACCESSWIRE / May 24, 2021 / Apollo Endosurgery, Inc. ("Apollo") (Nasdaq:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, announced...

3 months ago - Accesswire

Apollo Endosurgery to Present at Sidoti Conference May 20

AUSTIN, TX / ACCESSWIRE / May 12, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures today announced...

4 months ago - Accesswire

Apollo Endosurgery, Inc. (APEN) Reports Q1 Loss, Tops Revenue Estimates

Apollo Endosurgery, Inc. (APEN) delivered earnings and revenue surprises of 10.53% and 17.63%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

4 months ago - Zacks Investment Research

Apollo Endosurgery, Inc. Reports 29% Increase in First Quarter Revenue

Conference Call to Discuss Results Today at 3:30 p.m. CT / 4:30 p.m.

4 months ago - Accesswire

Apollo Endosurgery Announces Appointments to Commercial Leadership Team

Kirk Ellis to Serve as Vice President of US Sales Steve Bosrock to Serve as Vice President of Marketing & Medical Education AUSTIN, TX / ACCESSWIRE / May 3, 2021 / Apollo Endosurgery, Inc. ("Apollo") (N...

4 months ago - Accesswire

Apollo Endosurgery to Report First Quarter Financial Results on May 4, 2021

AUSTIN, TX / ACCESSWIRE / April 28, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in next-generation minimally invasive medical devices for gastrointestinal and bariatric pro...

4 months ago - Accesswire

Will Apollo Endosurgery, Inc. (APEN) Report Negative Q1 Earnings? What You Should Know

Apollo Endosurgery, Inc. (APEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

4 months ago - Zacks Investment Research

Apollo Endosurgery Announces Publication of Pre-Clinical Results for X-Tack(TM) Endoscopic HeliX Tacking System

Authors conclude, " Compared to TTS clip, X-Tack is superior for effecting large mucosal defect closure, including durable sealing of full-thickness perforation. " AUSTIN, TX / ACCESSWIRE / April 21, 20...

4 months ago - Accesswire

Apollo Endosurgery Announces Inducement Grant

AUSTIN, TX / ACCESSWIRE / March 19, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, announc...

6 months ago - Accesswire

Apollo Endosurgery announces AMA assignment of Category I CPT Codes for use in Intragastric Balloon Procedures

AUSTIN, TX / ACCESSWIRE / March 8, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, announce...

6 months ago - Accesswire

Apollo Endosurgery to Present at HC Wainwright Global Life Sciences Conference

AUSTIN, TX / ACCESSWIRE / March 3, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announc...

6 months ago - Accesswire

Apollo Endosurgery Receives FDA Breakthrough Device Designation for the Orbera(R) Intragastric Balloon for Treatment ...

AUSTIN, TX / ACCESSWIRE / March 1, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, announce...

6 months ago - Accesswire

Apollo Endosurgery's Earnings: A Preview

Apollo Endosurgery (NASDAQ:APEN) announces its next round of earnings this Thursday, February 25. Here is Benzinga's everything-that-matters guide for this Thursday's Q4 earnings announcement.

6 months ago - Benzinga

Apollo Endosurgery to Present at HC Wainwright Bioconnect Conference

AUSTIN, TX / ACCESSWIRE / January 5, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures today announ...

8 months ago - Accesswire

SHAREHOLDER ALERT: WeissLaw LLP Investigates Apollo Endosurgery, Inc.

NEW YORK, Sept. 1, 2020 /PRNewswire/ -- URGENT: SHAREHOLDER VOTE OCTOBER 7, 2020 WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors o...

1 year ago - PRNewsWire

Apollo Endosurgery, Inc. (APEN) CEO Todd Newton on Q1 2020 Results - Earnings Call Transcript

Apollo Endosurgery, Inc. (APEN) CEO Todd Newton on Q1 2020 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Top Ranked Momentum Stocks to Buy for April 14th

Top Ranked Momentum Stocks to Buy for April 14th

Other symbols:AQSTFATEMRSN
1 year ago - Zacks Investment Research